
treatment is lower than the risk posed by the natural history of the TAA. Level of recommendation: Grade 2
(Weak), Quality of Evidence: C (Low)
TEVAR for IMH and PAU. As mentioned previously,
IMH, PAU, and AD may be similar pathologic processes
along a spectrum of aortic disease or may occur in isolation, and therefore a discussion of the use of TEVAR for
dissection will be undertaken in another SVS document